<--- Back to Details
First PageDocument Content
Health / Medicine / Breakthrough therapy / Specialty drugs / Gilead Sciences / Healthcare-associated infections / Cyclopropanes / Sofosbuvir / Ledipasvir / National Institute for Health and Care Excellence / Hepatitis / National Health Service
Date: 2016-07-02 14:50:25
Health
Medicine
Breakthrough therapy
Specialty drugs
Gilead Sciences
Healthcare-associated infections
Cyclopropanes
Sofosbuvir
Ledipasvir
National Institute for Health and Care Excellence
Hepatitis
National Health Service

Microsoft Word - GILEAD BRIEFING

Add to Reading List

Source URL: www.ukts.org

Download Document from Source Website

File Size: 102,77 KB

Share Document on Facebook

Similar Documents

Breakthrough Cancer Therapy DTC

Breakthrough Cancer Therapy DTC

DocID: 1sYyU - View Document

Microsoft Word - GILEAD BRIEFING

Microsoft Word - GILEAD BRIEFING

DocID: 1r2Vm - View Document

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

DocID: 1qWZQ - View Document

24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box

DocID: 1qVSm - View Document

12-AUG:10 CANCER CONTROL ACCRUAL REPORT STUDY  O

12-AUG:10 CANCER CONTROL ACCRUAL REPORT STUDY O

DocID: 1qRuM - View Document